Caribou Biosciences

Price & Volume

Stats

52W Range	$1.01-$7.61
Market Cap	$105M
Shares Short	8M

Financials

Revenue (12 Mos)	$11.4M
Revenue Growth (YoY)	-91.4%
Gross Profit (12 Mos)	-$119.4M
Diluted EPS	-$1.66

News

Yahoo Finance • 2 days ago

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Yahoo Finance • 12 days ago

Caribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 24, 2025 Deadline to file Lead Plaintiff Motion

Yahoo Finance • 13 days ago

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. (CRBU) Shareholders

Yahoo Finance • 15 days ago

CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBU

About

CEO	Dr. Rachel E. Haurwitz Ph.D.
Address	2929 7th Street, Berkeley, CA, United States, 94710
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	158